株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の整形外科用ヒアルロン酸関節内補充療法の分析

US Market Report for Orthopedic Hyaluronic Acid Viscosupplementation 2017 - MedCore

発行 iData Research Inc. 商品コード 454935
出版日 ページ情報 英文 464 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.57円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の整形外科用ヒアルロン酸関節内補充療法の分析 US Market Report for Orthopedic Hyaluronic Acid Viscosupplementation 2017 - MedCore
出版日: 2017年03月01日 ページ情報: 英文 464 Pages
概要

当レポートでは、米国における整形外科向けヒアルロン酸関節内補充療法の市場について分析し、全体的な市場規模の動向見通し (販売量・収益額・平均価格、市場成長率など) や、手法別 (1/2/3/5回投与サイクル)・製品種類別 の詳細動向、主な市場促進・抑制要因、近年の資本取引・市場競争動向、企業別の市場シェアなどを調査すると共に、市場の全体的傾向 (疾患・製品の概要、処置件数、治験動向ほか) に関する情報も取りまとめてお届けいたします。

エグゼクティブ・サマリー

米国の整形外科用バイオマテリアル (生体材料) 市場:概略

競争分析

市場の傾向

市場の発展

処置件数

分析対象市場

主要分析の更新状況

過去のバージョン

分析手法

  • 分析範囲
  • IDATAの9段階の分析方法

疾患概要

  • 基本構造
    • 骨格・筋骨格系
  • 疾患の症状・障害
    • 全般的な診断
    • 骨粗しょう症
    • 変形性関節症(OA)
    • 骨移植処置の指標
    • 軟骨修復の指標
    • 変性円盤疾患(DDD)
  • 患者の人口構造
    • 一般統計データ

製品評価

  • 製品ポートフォリオ
    • ヒアルロン酸関節内補充療法
  • 規制上の問題とリコール
  • 治験

ヒアルロン酸関節内補充療法市場

  • イントロダクション
    • 関節内補充療法の利点
    • 関節液
    • 製品の種類
      • 単回投与製品
      • 二回投与サイクル製品
      • 三回投与サイクル製品
      • 三回/五回投与サイクル製品
    • 医療費償還
  • 市場概要
  • 市場の分析と予測
    • ヒアルロン酸関節内補充療法市場:全体
      • 単回投与製品
      • 二回投与サイクル製品
      • 三回投与サイクル製品
      • 三回/五回投与サイクル製品
  • 市場促進・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 企業別市場シェア分析

略語一覧

付録:各企業のプレスリリース

図表一覧

目次
Product Code: iDATA_USOB17_MC_HA

Osteoarthritis, which is a condition marked by the degeneration of bone joints and cartilage, affected approximately 40 million people in the United States in 2016. Patients who suffer from osteoarthritis experience acute joint pain, tenderness, stiffness, creaking, locking of the joints and inflammation. These symptoms are caused by the degeneration of joint cartilage, subchondral bone and synovial fluid, specifically the polysaccharide hyaluronate. Cartilage and synovial fluid are important for absorbing stress and cushioning joints during normal activity. Progressive deterioration of cartilage and an overactive immune response may also lead to muscle atrophy and chronic disability.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Hyaluronic acid products involve one-, two-, three- or five-dose cycles, with the actual number of doses taken often being less than a full treatment. The growth of single-injection products over three- and five-injection products has been the most significant trend in the market. The single-injection has, to some extent, cannibalized other injection types; the convenience of the single-injection procedure has aided market penetration. The introduction of a two injection product in 2016 will further squeeze market share from the three- and five-injection products. Furthermore, viscosupplementation is beginning to be an expected treatment before joint replacement; this will drive unit sales growth.

As of 2016, both the single-injection and triple-injection markets were approximately the same in terms of market value, with the triple-injection being a little larger. While the three-injection market continues its positive growth, the collective hyaluronic acid viscosupplementation market is shifting to single-injection. The single-injection market is expected to become the largest segment of the HA market in the next couple of years because due to ease-of-use.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
    • 2.1.1. Osteology and Musculoskeletal System
  • 2.2. DISEASE PATHOLOGY AND DISORDERS
    • 2.2.1. General Diagnostic
    • 2.2.2. Osteoporosis
    • 2.2.3. Osteoarthritis
    • 2.2.4. Indication for Bone Graft Procedure
    • 2.2.5. Indication for Cartilage Repair
    • 2.2.6. Degenerative Disc Disease
  • 2.3. PATIENT DEMOGRAPHICS
    • 2.3.1. General Statistics

PRODUCT ASSESSMENT

  • 3.1. PRODUCT PORTFOLIOS
    • 3.1.1. Hyaluronic Acid Viscosupplementation
  • 3.2. REGULATORY ISSUES AND RECALLS
    • 3.2.1. Hyaluronic Acid Viscosupplementation
  • 3.3. CLINICAL TRIALS
    • 3.3.1. Hyaluronic Acid Viscosupplementation

ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 4.1. INTRODUCTION
    • 4.1.1. Benefits of Viscosupplementation
    • 4.1.2. Synovial Fluid
    • 4.1.3. Product Types
      • 4.1.3.1. Single-Injection Products
      • 4.1.3.2. Two-Injection Cycle Products
      • 4.1.3.3. Three-Injection Cycle Products
      • 4.1.3.4. Three/Five-Injection Cycle Products
    • 4.1.4. Reimbursement
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Total Hyaluronic Acid Viscosupplementation Market
      • 4.3.1.1. Single-Injection Hyaluronic Acid Viscosupplementation Market
      • 4.3.1.2. Three-Injection Hyaluronic Acid Viscosupplementation Market
      • 4.3.1.3. Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX II: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023
  • Chart 1-2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
  • Chart 4-1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2013 - 2023
  • Chart 4-2: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2016
  • Chart 4-3: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2023
  • Chart 4-4: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Chart 4-5: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Chart 4-6: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Chart 4-7: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Chart 4-8: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016

LIST OF FIGURES

  • Figure 1-1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (1 of 2)
  • Figure 1-2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (2 of 2)
  • Figure 1-3: Companies Researched in this Report, U.S., 2016
  • Figure 1-4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2)
  • Figure 1-5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2)
  • Figure 1-6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2013 - 2016
  • Figure 1-7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 of 2)
  • Figure 1-8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 of 2)
  • Figure 1-9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 of 3)
  • Figure 3-1: Hyaluronic Acid Viscosupplementationby Products by Company
  • Figure 3-2: Class 3 Device Recall Euflexxa (1 sodium hyaluronate)
  • Figure 3-3: Trial Comparing Botulin Toxin Versus Hyaluronic Acid by Intra-articular Injection (GOTOX)
  • Figure 3-4: Trial to Assess the Structural Effect and Long-term Symptomatic Relief of Intra-articular Injections of HA (ViscOA)
  • Figure 3-5: Platelet-rich Plasma vs. Hyaluronic Acid for Glenohumeral Osteoarthritis
  • Figure 3-6: Comparative Assessment of Viscosupplementation With Polynucleotides and Hyaluronic Acid (PNHA1401)
  • Figure 3-7: To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection
  • Figure 3-8: Platelet-rich Plasma vs Viscosupplementation in the Treatment of Knee Articular Degenerative Pathology (PRP)
  • Figure 3-9: Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy
  • Figure 3-10: Effectiveness of Two Hyaluronic Acids in Osteoarthritis of the Knee
  • Figure 4-1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2013 - 2023 (US$M)
  • Figure 4-2: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Figure 4-3: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Figure 4-4: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Figure 4-5: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
  • Figure 4-6: Drivers and Limiters, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016
  • Figure 4-7: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016
  • Figure 6-1: Press Release Summary
Back to Top